VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q46256121 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233142.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q46256121‏
024 ‎‡a 0000-0002-0216-1014‏ ‎‡2 orcid‏
024 ‎‡a 35400919300‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q46256121‏
100 0 ‎‡a Sydney M. Evans‏ ‎‡9 ast‏ ‎‡9 sl‏
400 0 ‎‡a Sydney M. Evans‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Sydney M. Evans‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Sydney M. Evans‏ ‎‡c investigador/a‏ ‎‡9 es‏
670 ‎‡a Author's 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.‏
670 ‎‡a Author's A model of wound healing in chronically radiation-damaged rat skin‏
670 ‎‡a Author's Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma‏
670 ‎‡a Author's Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings‏
670 ‎‡a Author's Comment on the hypothesis that hyperthermia facilitates reoxygenation.‏
670 ‎‡a Author's Correlation between the light scattering and the mitochondrial content of normal tissues and transplantable rodent tumors.‏
670 ‎‡a Author's Cysteine concentrations in rodent tumors: unexpectedly high values may cause therapy resistance.‏
670 ‎‡a Author's Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.‏
670 ‎‡a Author's EF5 binding and clinical outcome in human soft tissue sarcomas‏
670 ‎‡a Author's Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy‏
670 ‎‡a Author's Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations.‏
670 ‎‡a Author's Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode‏
670 ‎‡a Author's Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.‏
670 ‎‡a Author's Hypoxia is important in the biology and aggression of human glial brain tumors.‏
670 ‎‡a Author's Improved Methods to Generate Spheroid Cultures from Tumor Cells, Tumor Cells & Fibroblasts or Tumor-Fragments: Microenvironment, Microvesicles and MiRNA.‏
670 ‎‡a Author's In regard to Brown et al.‏
670 ‎‡a Author's In regard to Brown et al. (Int J Radiat Oncol Biol Phys 2010;78:323-327).‏
670 ‎‡a Author's In situ oxygen utilization in the rat intervertebral disc‏
670 ‎‡a Author's In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.‏
670 ‎‡a Author's Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.‏
670 ‎‡a Author's Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker‏
670 ‎‡a Author's MIBG inhibits respiration: potential for radio- and hyperthermic sensitization.‏
670 ‎‡a Author's Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients‏
670 ‎‡a Author's Optimizing hypoxia detection and treatment strategies‏
670 ‎‡a Author's Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding‏
670 ‎‡a Author's Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.‏
670 ‎‡a Author's Pharmacokinetic and pharmacodynamic modifiers of EF5 uptake and binding.‏
670 ‎‡a Author's Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.‏
670 ‎‡a Author's Proceedings of the Oxygen Homeostasis/Hypoxia Meeting‏
670 ‎‡a Author's Prognostic significance of tumor oxygenation in humans.‏
670 ‎‡a Author's Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosis.‏
670 ‎‡a Author's Radiation dosimetry and biodistribution of the hypoxia tracer‏
670 ‎‡a Author's Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.‏
670 ‎‡a Author's Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas.‏
670 ‎‡a Author's Re: Devic et al. (Int J Radiat Oncol Biol Phys 2010;78:1555-1562)‏
670 ‎‡a Author's Synthesis of new hypoxia markers EF1 and [18F]-EF1‏
670 ‎‡a Author's The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake‏
670 ‎‡a Author's The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study‏
909 ‎‡a (orcid) 0000000202161014‏ ‎‡9 1‏
909 ‎‡a (scopus) 35400919300‏ ‎‡9 1‏
919 ‎‡a commentonthehypothesisthathyperthermiafacilitatesreoxygenation‏ ‎‡A Comment on the hypothesis that hyperthermia facilitates reoxygenation.‏ ‎‡9 1‏
919 ‎‡a cysteineconcentrationsinrodenttumorsunexpectedlyhighvaluesmaycausetherapyresistance‏ ‎‡A Cysteine concentrations in rodent tumors: unexpectedly high values may cause therapy resistance.‏ ‎‡9 1‏
919 ‎‡a detectionofhypoxiccellswiththe2nitroimidazoleef5correlateswithearlyredoxchangesinratbrainafterperinatalhypoxiaischemia‏ ‎‡A Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.‏ ‎‡9 1‏
919 ‎‡a ef5bindingandclinicaloutcomeinhumansofttissuesarcomas‏ ‎‡A EF5 binding and clinical outcome in human soft tissue sarcomas‏ ‎‡9 1‏
919 ‎‡a epidermalgrowthfactorreceptorinhibitionmodulatesthemicroenvironmentbyvascularnormalizationtoimprovechemotherapyandradiotherapyefficacy‏ ‎‡A Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy‏ ‎‡9 1‏
919 ‎‡a humanesophagealcancerisdistinguishedfromadjacentesophagealtissuebytissuecysteineconcentrations‏ ‎‡A Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations.‏ ‎‡9 1‏
919 ‎‡a hypoxiaandnecrosisinrat9lgliomaandmorris7777hepatomatumorscomparativemeasurementsusingef5bindingandtheeppendorfneedleelectrode‏ ‎‡A Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode‏ ‎‡9 1‏
919 ‎‡a hypoxiaandphotofrinuptakeintheintraperitonealcarcinomatosisandsarcomatosisofphotodynamictherapypatients‏ ‎‡A Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.‏ ‎‡9 1‏
919 ‎‡a hypoxiaisimportantinthebiologyandaggressionofhumanglialbraintumors‏ ‎‡A Hypoxia is important in the biology and aggression of human glial brain tumors.‏ ‎‡9 1‏
919 ‎‡a improvedmethodstogeneratespheroidculturesfromtumorcellstumorcellsandfibroblastsortumorfragmentsmicroenvironmentmicrovesiclesandmirna‏ ‎‡A Improved Methods to Generate Spheroid Cultures from Tumor Cells, Tumor Cells & Fibroblasts or Tumor-Fragments: Microenvironment, Microvesicles and MiRNA.‏ ‎‡9 1‏
919 ‎‡a inregardtobrownetal‏ ‎‡A In regard to Brown et al.‏ ‎‡9 1‏
919 ‎‡a inregardtobrownetalintjradiatoncolbiolphys201078323327‏ ‎‡A In regard to Brown et al. (Int J Radiat Oncol Biol Phys 2010;78:323-327).‏ ‎‡9 1‏
919 ‎‡a insituoxygenutilizationintheratintervertebraldisc‏ ‎‡A In situ oxygen utilization in the rat intervertebral disc‏ ‎‡9 1‏
919 ‎‡a invivoprofilingofhypoxicgeneexpressioningliomasusingthehypoxiamarkeref5andlasercapturemicrodissection‏ ‎‡A In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.‏ ‎‡9 1‏
919 ‎‡a initialevidencethatbloodbornemicrovesiclesarebiomarkersforrecurrenceandsurvivalinnewlydiagnosedglioblastomapatients‏ ‎‡A Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.‏ ‎‡9 1‏
919 ‎‡a interlaboratoryvariationinoxygentensionmeasurementbyeppendorfhistographandcomparisonwithhypoxicmarker‏ ‎‡A Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker‏ ‎‡9 1‏
919 ‎‡a mibginhibitsrespirationpotentialforradioandhyperthermicsensitization‏ ‎‡A MIBG inhibits respiration: potential for radio- and hyperthermic sensitization.‏ ‎‡9 1‏
919 ‎‡a microvesiclesasabiomarkerfortumorprogressionversustreatmenteffectinradiationtemozolomidetreatedglioblastomapatients‏ ‎‡A Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients‏ ‎‡9 1‏
919 ‎‡a optimizinghypoxiadetectionandtreatmentstrategies‏ ‎‡A Optimizing hypoxia detection and treatment strategies‏ ‎‡9 1‏
919 ‎‡a oxygenlevelsinnormalandpreviouslyirradiatedhumanskinasassessedbyef5binding‏ ‎‡A Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding‏ ‎‡9 1‏
919 ‎‡a patternsandlevelsofhypoxiainheadandnecksquamouscellcarcinomasandtheirrelationshiptopatientoutcome‏ ‎‡A Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.‏ ‎‡9 1‏
919 ‎‡a pharmacokineticandpharmacodynamicmodifiersofef5uptakeandbinding‏ ‎‡A Pharmacokinetic and pharmacodynamic modifiers of EF5 uptake and binding.‏ ‎‡9 1‏
919 ‎‡a pharmacokineticsofef5inhumanpatientsimplicationsforhypoxiameasurementsinvivoby2nitroimidazoles‏ ‎‡A Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.‏ ‎‡9 1‏
919 ‎‡a proceedingsoftheoxygenhomeostasishypoxiameeting‏ ‎‡A Proceedings of the Oxygen Homeostasis/Hypoxia Meeting‏ ‎‡9 1‏
919 ‎‡a prognosticsignificanceoftumoroxygenationinhumans‏ ‎‡A Prognostic significance of tumor oxygenation in humans.‏ ‎‡9 1‏
919 ‎‡a quantitativecomparisonoftissueoxygenandmotexafinlutetiumuptakebyexvivoandnoninvasiveinvivotechniquesinpatientswithintraperitonealcarcinomatosis‏ ‎‡A Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosis.‏ ‎‡9 1‏
919 ‎‡a radiationdosimetryandbiodistributionofthehypoxiatracer‏ ‎‡A Radiation dosimetry and biodistribution of the hypoxia tracer‏ ‎‡9 1‏
919 ‎‡a radiationdosimetryandbiodistributionofthehypoxiatracer18fef5inoncologicpatients‏ ‎‡A Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.‏ ‎‡9 1‏
919 ‎‡a radiationpluslocalhyperthermiaversusradiationplusthecombinationoflocalandwholebodyhyperthermiaincaninesarcomas‏ ‎‡A Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas.‏ ‎‡9 1‏
919 ‎‡a redevicetalintjradiatoncolbiolphys2010781555‏ ‎‡A Re: Devic et al. (Int J Radiat Oncol Biol Phys 2010;78:1555-1562)‏ ‎‡9 1‏
919 ‎‡a synthesisofnewhypoxiamarkersef1andef1‏ ‎‡A Synthesis of new hypoxia markers EF1 and [18F]-EF1‏ ‎‡9 1‏
919 ‎‡a radiationresponseofcellsfrom9lgliosarcomatumoursiscorrelatedwithef5uptake‏ ‎‡A The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake‏ ‎‡9 1‏
919 ‎‡a relationshipamonghypoxiaproliferationandoutcomeinpatientswithdenovoglioblastomaapilotstudy‏ ‎‡A The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study‏ ‎‡9 1‏
919 ‎‡a correlationbetweenthelightscatteringandthemitochondrialcontentofnormaltissuesandtransplantablerodenttumors‏ ‎‡A Correlation between the light scattering and the mitochondrial content of normal tissues and transplantable rodent tumors.‏ ‎‡9 1‏
919 ‎‡a 18fef5anewpettracerforimaginghypoxiainheadandneckcancer‏ ‎‡A 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.‏ ‎‡9 1‏
919 ‎‡a modelofwoundhealinginchronicallyradiationdamagedratskin‏ ‎‡A A model of wound healing in chronically radiation-damaged rat skin‏ ‎‡9 1‏
919 ‎‡a biodistributionanddosimetryof18fef5incancerpatientswithpreliminarycomparisonof18fef5uptakeversusef5bindinginhumanglioblastoma‏ ‎‡A Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma‏ ‎‡9 1‏
919 ‎‡a bonemarrowtransplantationinnewbornratswithmucopolysaccharidosistype6biochemicalpathologicalandclinicalfindings‏ ‎‡A Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings‏ ‎‡9 1‏
943 ‎‡a 156x‏ ‎‡A 1562‏ ‎‡9 1‏
996 ‎‡2 LC|no2007114365‏
996 ‎‡2 SUDOC|132435284‏
996 ‎‡2 ISNI|0000000498449921‏
996 ‎‡2 J9U|987007366915705171‏
996 ‎‡2 LC|no2017087995‏
996 ‎‡2 SUDOC|132094088‏
996 ‎‡2 RERO|A005650840‏
996 ‎‡2 LC|no2021136035‏
996 ‎‡2 LIH|LNB:CRQ__;=BM‏
996 ‎‡2 RERO|A013191453‏
996 ‎‡2 NUKAT|n 01091901‏
996 ‎‡2 LC|n 87885338‏
996 ‎‡2 KRNLK|KAC201890869‏
996 ‎‡2 ISNI|0000000114443281‏
996 ‎‡2 PLWABN|9810553781205606‏
996 ‎‡2 SUDOC|18961496X‏
996 ‎‡2 DNB|134369289‏
996 ‎‡2 NTA|356183939‏
996 ‎‡2 BIBSYS|7015422‏
996 ‎‡2 CAOONL|ncf10976952‏
996 ‎‡2 ISNI|0000000359291335‏
996 ‎‡2 BIBSYS|90641246‏
996 ‎‡2 LC|nb2016000792‏
996 ‎‡2 NII|DA02071123‏
996 ‎‡2 PLWABN|9811714347705606‏
996 ‎‡2 SUDOC|077301897‏
996 ‎‡2 LC|n 88211377‏
996 ‎‡2 ISNI|0000000041967083‏
996 ‎‡2 LC|n 88672618‏
996 ‎‡2 NUKAT|n 2018090201‏
996 ‎‡2 BIBSYS|97019513‏
996 ‎‡2 ISNI|000000004844906X‏
996 ‎‡2 NTA|440141346‏
996 ‎‡2 ISNI|0000000081189343‏
996 ‎‡2 SUDOC|068915977‏
996 ‎‡2 DE633|pe50054970‏
996 ‎‡2 NSK|000244777‏
996 ‎‡2 SUDOC|203156188‏
996 ‎‡2 BIBSYS|3036229‏
996 ‎‡2 J9U|987012277860205171‏
996 ‎‡2 JPG|500010189‏
996 ‎‡2 LC|n 81127792‏
996 ‎‡2 LC|no 92033266‏
996 ‎‡2 ISNI|0000000362936309‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏